Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.

Hale, Martin E; Zimmerman, Thomas R; Ma, Yuju; Malamut, Richard

Hale, Martin E; Zimmerman, Thomas R; Ma, Yuju; Malamut, Richard.

Affiliation

Hale ME; Assistant Clinical Professor, Nova Southeastern Medical College, Fort Lauderdale, Florida; Medical Director, Gold Coast Research, LLC, Plantation, Florida.
Zimmerman TR; Medical Monitor, Teva Pharmaceuticals, Frazer, Pennsylvania.
Ma Y; Associate Director, Statistics, Teva Pharmaceuticals, Frazer, Pennsylvania.
Malamut R; Vice President, Global Clinical Development, Pain Therapeutic Area Head, Teva Pharmaceuticals, Frazer, Pennsylvania.

J Opioid Manag ; 11(5): 425-34, 2015.

Article in En | MEDLINE | ID: mdl-26535970

Subject(s)

Chronic Pain/drug therapy; Hydrocodone/administration & dosage; Pain Management; Substance Abuse Detection/methods; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid/administration & dosage; Chronic Pain/diagnosis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain Measurement/methods; Time Factors; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance Abuse Detection / Chronic Pain / Pain Management / Hydrocodone Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Opioid Manag Journal subject: NEUROLOGIA / PSICOFISIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google